Systematic metabolic diseases are closely related to prevalence and progression of atherosclerosis. This prospective cohort consecutively enrolls patients with coronary artery disease compliacted with metabolic abnormalities such as diabtetes, prediabetes, obesity, chronic kidney disease and hyperuricemia.
CArdioMetabolism and Atherosclerotic PlaqUe progreSsion (CAMPUS) study is a single center, prospective cohort study to investigate the impact of cardiometabolic factors on coronary diseases. This study consecutively enrolls patients with coronary artery diseases complicatied with metabolic abnormalities, including diabetes, prediabetes, obesity, chronic kidney disease and hyperuricemia.
Study Type
OBSERVATIONAL
Enrollment
3,000
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, China
RECRUITINGCoronary plaque progression
Assessed by coronary angiography and QCA
Time frame: 12 months
Coronary lesion severity
Assessed by coronary angiography and QCA
Time frame: 12 months
Coronary plaque characteristics
Assessed by intravascular imaging (IVUS or OCT)
Time frame: 12 months
Cardiovascular events
The incidence of MACCE (major adverse cardio and cerebral vascular events), lesion associated events (target lesion myocardial infarction, target lesion faliure, target vessel revascularization, etc.)
Time frame: up to 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.